Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 22467520)

1.

Induction of angiogenesis and osteogenesis in surgically revascularized frozen bone allografts by sustained delivery of FGF-2 and VEGF.

Willems WF, Larsen M, Friedrich PF, Shogren KL, Bishop AT.

J Orthop Res. 2012 Oct;30(10):1556-62. doi: 10.1002/jor.22112. Epub 2012 Mar 29.

PMID:
22467520
2.

Revascularization and bone remodeling of frozen allografts stimulated by intramedullary sustained delivery of FGF-2 and VEGF.

Willems WF, Larsen M, Giusti G, Friedrich PF, Bishop AT.

J Orthop Res. 2011 Sep;29(9):1431-6. doi: 10.1002/jor.21338. Epub 2011 Mar 28.

PMID:
21445997
3.
4.

Effect of rhBMP-2 and VEGF in a vascularized bone allotransplant experimental model based on surgical neoangiogenesis.

Mattar T, Friedrich PF, Bishop AT.

J Orthop Res. 2013 Apr;31(4):561-6. doi: 10.1002/jor.22277. Epub 2012 Nov 28.

5.

Surgical revascularization in structural orthotopic bone allograft increases bone remodeling.

Willems WF, Kremer T, Friedrich P, Bishop AT.

Clin Orthop Relat Res. 2014 Sep;472(9):2870-7. doi: 10.1007/s11999-014-3658-y. Epub 2014 Jul 11.

PMID:
25011908
6.

Surgical revascularization induces angiogenesis in orthotopic bone allograft.

Willems WF, Kremer T, Friedrich P, Bishop AT.

Clin Orthop Relat Res. 2012 Sep;470(9):2496-502. doi: 10.1007/s11999-012-2442-0.

7.

Surgical angiogenesis: a new approach to maintain osseous viability in xenotransplantation.

Chung YG, Bishop AT, Giessler GA, Suzuki O, Platt JL, Pelzer M, Friedrich PF, Kremer T.

Xenotransplantation. 2010 Jan-Feb;17(1):38-47. doi: 10.1111/j.1399-3089.2009.00563.x.

PMID:
20149187
8.

Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.

Horio T, Fujita M, Tanaka Y, Ishihara M, Kishimoto S, Nakamura S, Hase K, Maehara T.

J Vasc Surg. 2011 Sep;54(3):791-8. doi: 10.1016/j.jvs.2011.02.060. Epub 2011 May 28.

9.

Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures.

Zhang L, Zhang L, Lan X, Xu M, Mao Z, Lv H, Yao Q, Tang P.

J Mater Sci Mater Med. 2014 Apr;25(4):1165-72. doi: 10.1007/s10856-013-5138-4. Epub 2014 Jan 17.

PMID:
24435526
10.

Fibroblast growth factor-2 and vascular endothelial growth factor mediated augmentation of angiogenesis and bone formation in vascularized bone allotransplants.

Larsen M, Willems WF, Pelzer M, Friedrich PF, Dadsetan M, Bishop AT.

Microsurgery. 2014 May;34(4):301-7. doi: 10.1002/micr.22221. Epub 2014 Jan 3.

11.

Short-term immunosuppression and surgical neoangiogenesis with host vessels maintains long-term viability of vascularized bone allografts.

Pelzer M, Larsen M, Chung YG, Ohno T, Platt JL, Friedrich PF, Bishop AT.

J Orthop Res. 2007 Mar;25(3):370-7.

PMID:
17106873
12.

Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.

Lozano D, Feito MJ, Portal-Núñez S, Lozano RM, Matesanz MC, Serrano MC, Vallet-Regí M, Portolés MT, Esbrit P.

Acta Biomater. 2012 Jul;8(7):2770-7. doi: 10.1016/j.actbio.2012.04.002. Epub 2012 Apr 6.

PMID:
22487933
14.

VEGF-promoted surgical angiogenesis in necrotic bone.

Suzuki O, Bishop AT, Sunagawa T, Katsube K, Friedrich PF.

Microsurgery. 2004;24(1):85-91.

PMID:
14748033
15.

Effects of VEGF and FGF-2 on proliferation and differentiation of human periodontal ligament stem cells.

Lee JH, Um S, Jang JH, Seo BM.

Cell Tissue Res. 2012 Jun;348(3):475-84. doi: 10.1007/s00441-012-1392-x. Epub 2012 Mar 23.

PMID:
22437875
16.

Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

De Laporte L, des Rieux A, Tuinstra HM, Zelivyanskaya ML, De Clerck NM, Postnov AA, Préat V, Shea LD.

J Biomed Mater Res A. 2011 Sep 1;98(3):372-82. doi: 10.1002/jbm.a.33112. Epub 2011 May 31.

17.

Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration.

Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ.

Biomaterials. 2009 May;30(14):2816-25. doi: 10.1016/j.biomaterials.2009.01.031. Epub 2009 Feb 20.

PMID:
19232714
18.

Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.

Formiga FR, Pelacho B, Garbayo E, Abizanda G, Gavira JJ, Simon-Yarza T, Mazo M, Tamayo E, Jauquicoa C, Ortiz-de-Solorzano C, Prósper F, Blanco-Prieto MJ.

J Control Release. 2010 Oct 1;147(1):30-7. doi: 10.1016/j.jconrel.2010.07.097. Epub 2010 Jul 17.

PMID:
20643169
19.

Site-specific delivery of acidic fibroblast growth factor stimulates angiogenic and osteogenic responses in vivo.

Kelpke SS, Zinn KR, Rue LW, Thompson JA.

J Biomed Mater Res A. 2004 Nov 1;71(2):316-25.

PMID:
15376268
20.

Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.

Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS.

Gene Ther. 2001 Apr;8(7):523-33.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk